Insider Trading disclosures for Cns Pharmaceuticals Inc

The latest disclosure was made by Amy Mahery in Cns Pharmaceuticals Inc where a trade of 17,500 Option to purchase common stock done was reported to US exchanges on April 8, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Amy Mahery	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	29,920	-		-	Option to purchase common stock
John M. Climaco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	83,000	559,533	-		-	Restricted Stock Units
John M. Climaco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	83,000	476,533	-		-	Option to purchase common stock
Jeffry R. Keyes	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	62,928	-		-	Option to purchase common stock
Jeffry R. Keyes	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	80,428	-		-	Restricted Stock Units
Christopher Downs	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	40,000	241	-		-	Restricted Stock Units
Christopher Downs	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	40,000	201	-		-	Option to purchase common stock
Faith L. Charles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	64,815	-		-	Restricted Stock Units
Faith L. Charles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	47,315	-		-	Option to purchase common stock
Jerzy Gumulka	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	147,594	-		-	Restricted Stock Units
Jerzy Gumulka	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	129,594	-		-	Option to purchase common stock
Carl Evans	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	147,094	-		-	Restricted Stock Units
Carl Evans	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	129,594	-		-	Option to purchase common stock
Bettina M. Cockroft	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	35,574	-		-	Option to purchase common stock
Bettina M. Cockroft	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	53,074	-		-	Restricted Stock Units
Amy Mahery	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	47,420	-		-	Restricted Stock Units
Gumulka Jerzy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	33,333	78,761	-		-	Series A Warrant to purchase common stock
John M. Climaco	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.30 per share.	01 Feb 2024	166,666	215,676 (1%)	1%	0.3	50,000	Common stock
Carl Evans	Director	Purchase of securities on an exchange or from another person at price $ 0.30 per share.	01 Feb 2024	33,333	33,458 (0%)	0%	0.3	10,000	Common stock
Gumulka Jerzy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	33,333	112,094	-		-	Series B Warrant to purchase common stock
Carl Evans	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	33,333	78,761	-		-	Series A Warrant to purchase common stock
Downs Christopher	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.30 per share.	01 Feb 2024	66,666	103,438 (0%)	0%	0.3	20,000	Common stock
Downs Christopher	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	66,666	94,906	-		-	Series A Warrant to purchase common stock
M. John Climaco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	166,666	226,867	-		-	Series A Warrant to purchase common stock
Mahery Amy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	12,420	12,420	-		-	Option to purchase common stock
Gumulka Jerzy	Director	Purchase of securities on an exchange or from another person at price $ 0.30 per share.	01 Feb 2024	33,333	43,006 (0%)	0%	0.3	10,000	Common stock
Downs Christopher	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	66,666	161,572	-		-	Series B Warrant to purchase common stock
M. John Climaco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	166,666	393,533	-		-	Series B Warrant to purchase common stock
Evans Carl	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	33,333	112,094	-		-	Series B Warrant to purchase common stock
Christopher Downs	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 1.27 per share.	22 Aug 2023	27,000	36,772 (0%)	0%	1.3	34,177	Common Stock
John M. Climaco	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.80 per share.	16 Aug 2023	2,750	49,010 (0%)	0%	1.8	4,945	Common Stock
Bettina M. Cockroft	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 May 2023	2,099	2,099	-		-	Option to purchase common stock
John M. Climaco	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2023	1,250	60,201	-		-	Restricted Stock Units
John M. Climaco	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2023	1,250	46,260 (0%)	0%		-	Common Stock
Christopher Downs	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2023	521	9,772 (0%)	0%		-	Common Stock
Christopher Downs	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2023	521	28,248	-		-	Restricted Stock Units
Jerzy Gumulka	Director	Purchase of securities on an exchange or from another person at price $ 1.70 per share.	19 Apr 2023	2,500	9,673 (0%)	0%	1.7	4,250	Common Stock
Christopher Downs	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 3.20 per share.	17 Apr 2023	3,100	9,251 (0%)	0%	3.2	9,920	Common Stock
John M. Climaco	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.69 per share.	12 Apr 2023	15,000	45,010 (0%)	0%	0.7	10,409	Common Stock
Jerzy Gumulka	Director	Purchase of securities on an exchange or from another person at price $ 0.74 per share.	10 Apr 2023	7,173	7,173 (0%)	0%	0.7	5,308	Common Stock
John M. Climaco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2023	16,467	61,451	-		-	Restricted Stock Units
Christopher Downs	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Mar 2023	6,067	28,768	-		-	Restricted Stock Units
Faith L. Charles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Dec 2022	3,500	3,500	-		-	Option to purchase common stock
Christopher Downs	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2022	250,000	681,000	-		-	Restricted Stock Units
John M. Climaco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2022	600,000	1,349,500	-		-	Restricted Stock Units
Christopher Downs	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.31 per share.	11 Mar 2022	33,000	184,500 (1%)	0%	0.3	10,230	Common Stock
Carl Evans	Director	Grant, award, or other acquisition of securities at price $ 0.27 per share.	08 Mar 2022	3,750	3,750 (0%)	0%	0.3	1,005	Common Stock
Jeffry R. Keyes	Director	Grant, award, or other acquisition of securities at price $ 0.30 per share.	07 Mar 2022	11,100	11,100 (0%)	0%	0.3	3,294	Common Stock
John M. Climaco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.28 per share.	07 Mar 2022	35,000	940,298 (5%)	0%	0.3	9,835	Common Stock
Christopher Downs	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.94 per share.	06 Dec 2021	5,000	151,500 (0%)	0%	0.9	4,702	Common Stock

Showing 1 to 50 of 64 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

99.72% Fall from 52W High

Insider Trading disclosures for Cns Pharmaceuticals Inc

The latest disclosure was made by Amy Mahery in Cns Pharmaceuticals Inc where a trade of 17,500 Option to purchase common stock done was reported to US exchanges on April 8, 2024.

Screeners based on Insider Trading and SAST parameters